Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008

Vaccine

Volumn 30, Issue 19, 2012, Pages 2999-3002

  Snijders, Bianca E P ^a,b   Lier, Alies van ^a   van de Kassteele, Jan ^a   Fanoy, Ewout B ^a,c   Ruijs, Wilhelmina L M ^a,c   Hulshof, Folkwin ^c   Blauwhof, Annet ^c   Schipper, Maarten ^a   van Binnendijk, Rob ^a   Boot, Hein J ^a   de Melker, Hester E ^a   Hahné, Susan J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Pallas Health Research and Consultancy   (Netherlands)

^c Municipal Health Service   (Netherlands)

Author keywords

Children; Cross sectional study; Household contacts; Mumps; Vaccine effectiveness

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CROSS-SECTIONAL STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MUMPS; NETHERLANDS; ORCHITIS; OTALGIA; OTITIS; PANCREATITIS; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; MUMPS; MUMPS VACCINE; NETHERLANDS; PREVALENCE; QUESTIONNAIRES; SCHOOLS;

EID: 84859428832     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.035     Document Type: Article

References (15)

1. Plotkin S.A., Orenstein W.A., Offit P.A. Vaccines 2008, Saunders Elsevier, Philadelphia. 5th ed.
2. Hviid A., Rubin S., Muhlemann K. Mumps. Lancet 2008, 371(March (9616)):932-944.
3. van den Hof S., Beaumont M.T., Berbers G.A., de Melker H.E. Antibodies against mumps in the Netherlands as assessed by indirect ELISA and virus neutralization assay. Epidemiol Infect 2003, August (131)(1):703-709.
4. de Melker HE, van Lier EA. The National Immunisation Programme in the Netherlands. Report 210021009/2009 2008.
5. Eliminating measles and rubella and preventing congenital rubella infection: WHO European Region strategic plan 2005-2010. ISBN 92 890 1382 6.
6. van Lier E.A., Oomen P.J., Oostenbrug M.W., Zwakhals S.L., Drijfhout I.H., de Hoogh P.A., et al. High vaccination coverage of the National Immunization Programme in the Netherlands. Ned Tijdschr Geneeskd 2009, 153(May (20)):950-957.
7. Hirasing R.A., Schaapveld K. Vaccination against mumps successful. Ned Tijdschr Geneeskd 1993, 137(July (30)):1498-1500.
8. Brockhoff H.J., Mollema L., Sonder G.J., Postema C.A., van Binnendijk R.S., Kohl R.H., et al. Mumps outbreak in a highly vaccinated student population, the Netherlands, 2004. Vaccine 2010, 28(April (17)):2932-2936.
9. Wielders C.C., van Binnendijk R.S., Snijders B.E., Tipples G.A., Cremer J., Fanoy E., et al. Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill 2011, 16(October (41)).
10. Halloran M.E., Longini I.M., Struchiner C.J. Design and Analysis of Vaccine Studies Statistics for Biology and Health 2010, Springer, New York. 1st ed.
11. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007, 13(January (1)):12-17.
12. Peltola H., Kulkarni P.S., Kapre S.V., Paunio M., Jadhav S.S., Dhere R.M. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007, 45(August (4)):459-466.
13. Becker N.G., Britton T., O'Neill P.D. Estimating vaccine effects from studies of outbreaks in household pairs. Stat Med 2006, 25(March (6)):1079-1093.
14. Fanoy E.B., Cremer J., Ferreira J.A., Dittrich S., van Lier A., Hahne S.J., et al. Transmission of mumps virus from mumps-vaccinated individuals to close contacts. Vaccine 2011, 29(November (51)):9551-9556.
15. Dayan G.H., Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis 2008, 47(December (11)):1458-1467.